The burden of anaemia demonstrated in this study was similar to the high burden found in CKD populations elsewhere, including one done by Gjata et al. in Albania that showed a 100% frequency,11 and another from Nigeria where a high proportion of CKD patients with left ventricular hypertrophy (LVH) were found to be anaemic.10 The high prevalence of anaemia in all these settings is probably due to the similarity of pathogenesis, lack of erythropoietin, the most important factor in anaemia of CKD. This evidence concerns the gene EPO and anemia.